Glioblastomas with an oligodendroglial component: a pathological and molecular study. - Wikidata - wikimedia - TriplyDB

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

http://www.wikidata.org/entity/Q48793195

about

The 2007 WHO classification of tumours of the central nervous system A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1 FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.Present and potential future issues in glioblastoma treatment.Prognostic stratification of patients with anaplastic gliomas according to genetic profile.Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas.OLIG-1 and 2 gene expression and oligodendroglial tumours.Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.Pten signaling in gliomas.Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas Oligodendrogliomas: an update on basic and clinical research.Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma.Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome Pathology and molecular genetics of astrocytic gliomas.Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells.A multi-resolution textural approach to diagnostic neuropathology reporting.Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.Molecular markers in gliomas: impact for the clinician.Predictive and prognostic factors for gliomas.Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.Intraoperative diagnosis of glioblastomamultiforme with oligodendroglial and sarcomatous components.Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.[Oligodendroglial and neuronal component in glioblastomas: possible relation with prognosis].Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis.Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.

P2860

Q24685772-93665C86-2B83-4709-A675-C690E000A7AD Q27304385-BC630C02-F380-4D50-9458-D197869A2669 Q28297008-21803AF4-CE78-4B1F-B02A-6A75BC55DAB5 Q30984368-CB01F1D6-E870-4E8A-8151-0DA919F24361 Q31043603-3199F14F-2BA5-45D2-AC70-E43D489B164C Q33258125-3281785A-A33B-4733-B5B3-914A6E49D131 Q33260758-C6084508-7BCB-4836-A029-9D427D57620D Q33410196-9B2AB48F-2CF8-4BAA-A584-18F2E1020BC9 Q33588294-CCF5BE32-C82A-4BA3-A752-CFC31FDC29A7 Q33925544-44BC7B46-101F-45BF-9FA9-FB3AD7CB2E0B Q34105339-5BBA6F29-B205-4631-AC6D-E9FEC6160AD7 Q34105361-AA5713AA-B8B3-4BC2-B321-4B730E3950C0 Q34132650-A06648CA-B5FB-47E0-BB17-33B137268092 Q34612308-B738C66D-D0DB-4E36-AC5C-1AF26EC586C0 Q34650241-73F588D2-4E8C-4263-BEC2-809413FCD71F Q34707865-E980BB8E-D37F-4381-9099-A0806E345B17 Q34754083-993E0768-2083-4565-A79C-27B13594AD1E Q35028828-49BDE7C8-F4C6-4FAC-AAC0-A99D3C57BFEA Q35098051-20BD5942-E284-4695-8CAA-19BBDE980DE1 Q35105809-54706E1A-ED98-4B3C-B490-6B703ABD12DE Q35170377-D4FC9D04-E143-4A7B-A024-054079F439B2 Q35419379-AB8126EB-E890-42AA-BC4C-ED0EB72F7AD7 Q35845223-7DA7E2CA-66E1-4E03-B727-221CF13A7DC2 Q35865773-00AFEA93-D4BC-4232-BDD1-24D8C6841CCF Q36201775-BF5A9127-4130-49AD-AF7F-54BBFB8F9A47 Q36663072-5BA88943-116A-4D90-BF07-BAC2FEA3C22E Q36673557-BC6D05F9-6F39-4745-B887-45B3E320AAA3 Q36904087-CAB03059-84F5-4155-9538-8B6AC4AB4AB6 Q37038547-5EA0EE4A-179F-4CA0-9F2B-5FD691077E75 Q37312716-8CED73B2-006F-4B15-8D1B-93CBEE2C4B8F Q37784456-68632825-1C39-49DD-AFBA-E049614AE1B4 Q37873473-D874C513-4B08-4970-83A4-9A83AE628709 Q37976320-B01A8CDA-EE74-4F6E-8E07-1CA4FD1A4292 Q42155428-472D2248-DC87-486F-A886-E24626CB7F97 Q42779710-BC496800-8C26-43B9-A0A4-47498F2B948E Q43170049-88094856-558B-4D80-BBF3-82CBF75BD28D Q43584831-9D0ED5A8-A69F-480C-99BB-065EEAFB1C13 Q44230849-7DF2D7A2-FFDD-459E-8293-F45915F90D11 Q44293216-102095B9-ED4D-4046-BCBA-C47DB52884AC Q44435988-97766997-CC76-4DC7-ACD2-5CBABD30642D

P2860

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

http://www.wikidata.org/entity/Q48793195

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@en

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@nl

type

label

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@en

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@nl

prefLabel

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@en

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@nl

P1433

Q48793195-FA913E75-5640-40FC-84D3-F780682AE2D3

P1476

Q48793195-A6FD0B1B-ACF1-4DE6-A07E-B9D82FEF0ACD

P2093

Q48793195-01A653E6-A57D-4C32-9E1B-DD9B79901155

Q48793195-2199A9DD-7871-4D0C-9CC0-10E3A6436352

Q48793195-42D82492-9175-448B-9708-8F7FCEDD327F

Q48793195-7F9DB050-0500-44A2-829A-CDF35524FC09

Q48793195-88286E4D-DF06-46C0-B191-F7E1D310C34D

Q48793195-97FC3447-DBBA-4D1E-8283-F3C7865DB290

Q48793195-AA22B6C7-C0CA-4CBF-81E5-973B4DF37326

Q48793195-D08894DF-4C58-4D5D-A806-FF5D54B7C3D3

Q48793195-DCA049D5-5BA2-4BBD-A7E1-D47E5A34D06B

Q48793195-F2C445AC-9042-45C7-9FCD-AF859006BDEF

P2860

Q48793195-03467822-C294-481D-8534-697337B0C215

Q48793195-1DFFEB78-2F4D-4D9D-8836-CC5902C66EDA

Q48793195-2A8202C6-341A-4F46-A675-D4353EE1275C

Q48793195-31FB0C6A-EB7B-4D57-98A8-DF8D77205A0E

Q48793195-3229AD0C-F664-4A5F-AEE9-BC3EE951E54A

Q48793195-36FC67A0-C263-4165-A95D-06BCE800061E

Q48793195-4B6C9AFE-64AE-49AB-9E13-444C89927EBD

Q48793195-584C6A91-7DD8-48D3-9BD6-9D3FD73B099C

Q48793195-79843192-E0F9-4DFC-9DB3-38D91399DFA7

Q48793195-7F45FDB7-EEEF-4BA7-BB16-7891B067093F

P304

Q48793195-7DED97D5-C30A-4482-9E27-FB8C5646E95B

P31

Q48793195-C98C8E63-B081-489D-9091-A7E59C62768D

P356

Q48793195-4360FA7F-6378-4C37-B415-A1C06291B492

P433

Q48793195-637883EE-BA29-4648-ABF0-4510EA28FD13

P478

Q48793195-6BD92C26-2D59-4FBE-8734-7683D50C7045

P577

Q48793195-6F0C4146-561A-439F-BDE0-36F15575A2FF

P5875

Q48793195-AB56A316-366A-4CB8-9B70-AD8452CFF86C

P698

Q48793195-8F91B395-8F82-4230-952E-DBB6676F1C88

P921

Q48793195-AD1F7EB6-37F5-44E7-9C98-B3C6897339D9

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

@en

P2093

J He

http://www.w3.org/2001/XMLSchema#string

J Poirier

http://www.w3.org/2001/XMLSchema#string

J Y Delattre

http://www.w3.org/2001/XMLSchema#string

K Hoang-Xuan

http://www.w3.org/2001/XMLSchema#string

K Mokhtari

http://www.w3.org/2001/XMLSchema#string

L Capelle

http://www.w3.org/2001/XMLSchema#string

M Kujas

http://www.w3.org/2001/XMLSchema#string

M Sanson

http://www.w3.org/2001/XMLSchema#string

P Leuraud

http://www.w3.org/2001/XMLSchema#string

S Huguet

http://www.w3.org/2001/XMLSchema#string

P2860

A transcript map of the chromosome 19q-arm glioma tumor suppressor region

Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.

Growth factors, glia and gliomas.

Molecular pathogenesis of malignant gliomas.

Progression as exemplified by human astrocytic tumors.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.

Genetic alterations associated with the evolution and progression of astrocytic brain tumours.

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

P304

863-871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/60.9.863

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11790434

http://www.w3.org/2001/XMLSchema#string

P698

11556543

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte